📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nuclein

1.1 - Company Overview

Nuclein Logo

Nuclein

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of polymerase chain reaction test devices for infectious diseases, offering the DASH Rapid PCR System, a point-of-care platform that performs sample-to-answer PCR tests in 15 minutes for use in CLIA-waived environments.

Products and services

  • PCR Test Device Development: Architects polymerase chain reaction test device for infectious diseases, emphasizing point-of-care implementation and CLIA-waived suitability
  • DASH Rapid PCR System: A point-of-care platform performing sample-to-answer polymerase chain reaction tests for infectious diseases in 15 minutes, designed expressly for CLIA-waived environments
  • Point-of-Care Platform Engineering for CLIA-Waived Environments: Engineers platform tailored to CLIA-waived settings to perform sample-to-answer PCR tests in 15 minutes for infectious disease detection

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nuclein

Isconova Logo

Isconova

HQ: Sweden Website
  • Description: Provider of adjuvants and vaccines, developing and commercializing adjuvants for veterinary and human vaccines to enhance immune reactions with longer duration. Products include Matrix-M, inducing cell- and antibody-mediated immune responses for use in vaccines for humans and dogs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Isconova company profile →
LigoCyte Pharmaceuticals Logo

LigoCyte Pharmaceuticals

HQ: United States Website
  • Description: Provider of vaccines and monoclonal antibodies for gastrointestinal and respiratory indications, developing novel immunomodulatory drug compounds that modify immune responses by targeting cell binding interactions for the treatment of inflammatory and infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LigoCyte Pharmaceuticals company profile →
DeepUll Logo

DeepUll

HQ: Spain Website
  • Description: Provider of a biotech diagnostic system for early-stage sepsis that rapidly identifies pathogens and delivers an antibiogram within hours, leveraging patient immunological and functional data.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DeepUll company profile →
Viamet Pharmaceuticals Logo

Viamet Pharmaceuticals

HQ: United States Website
  • Description: Provider of small molecule inhibitors of validated metalloenzymes developed via a proprietary metal-binding approach (Metallophile Technology) for the treatment of various diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viamet Pharmaceuticals company profile →
Calixa Therapeutics Logo

Calixa Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical drug development focused on a novel cephalosporin to address multi-drug resistant organisms, targeting infections caused by resistant gram-negative bacteria, especially Pseudomonas aeruginosa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calixa Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nuclein

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nuclein

2.2 - Growth funds investing in similar companies to Nuclein

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nuclein

4.2 - Public trading comparable groups for Nuclein

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nuclein

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nuclein

What does Nuclein do?

Nuclein is a provider of polymerase chain reaction test devices for infectious diseases, offering the DASH Rapid PCR System, a point-of-care platform that performs sample-to-answer PCR tests in 15 minutes for use in CLIA-waived environments.

Who are Nuclein's competitors?

Nuclein's competitors and similar companies include Isconova, LigoCyte Pharmaceuticals, DeepUll, Viamet Pharmaceuticals, and Calixa Therapeutics.

Where is Nuclein headquartered?

Nuclein is headquartered in United States.

How many employees does Nuclein have?

Nuclein has 1,000 employees 🔒.

When was Nuclein founded?

Nuclein was founded in 2010 🔒.

What sector and industry vertical is Nuclein in?

Nuclein is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nuclein

Who are the top strategic acquirers in Nuclein's sector and industry

Top strategic M&A buyers and acquirers in Nuclein's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nuclein?

Top strategic M&A buyers groups and sectors for Nuclein include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nuclein's sector and industry vertical

Which are the top PE firms investing in Nuclein's sector and industry vertical?

Top PE firms investing in Nuclein's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nuclein's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nuclein's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nuclein's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nuclein include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nuclein's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nuclein?

The key public trading comparables and valuation benchmarks for Nuclein include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nuclein for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nuclein with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nuclein's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nuclein with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nuclein's' sector and industry vertical?

Access recent funding rounds and capital raises in Nuclein's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nuclein